Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or OpenAthens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Current Concepts in Movement Disorder Management

Editor(s): Niranjan A. (Pittsburgh, PA) 
Lunsford L.D. (Pittsburgh, PA) 
Richardson R.M. (Pittsburgh, PA) 
Cover

Radiosurgical Thalamotomy

Monaco III E.A. · Shin S.S. · Niranjan A. · Lunsford L.D.

Author affiliations

Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Related Articles for ""

Niranjan A, Lunsford LD, Richardson RM (eds): Current Concepts in Movement Disorder Management. Prog Neurol Surg. Basel, Karger, 2018, vol 33, pp 135-148

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of  

Published online: January 12, 2018
Cover Date: 2018

Number of Print Pages: 14
Number of Figures: 3
Number of Tables: 2

ISBN: 978-3-318-06201-4 (Print)
eISBN: 978-3-318-06202-1 (Online)

Abstract

Tremor is a common movement disorder that can be disabling, and its initial treatment is in the form of medical therapies. Often patients are refractory and seek surgical intervention. Treatment options for these patients include surgical radiofrequency thalamotomy and deep brain stimulation. There are a subset of patients who, for various reasons, are not candidates for open surgical procedures, or who opt to avoid them. For these patients, radiosurgical thalamotomy is a safe and useful alternative. Herein, we provide a review of the use of radiosurgical thalamotomy for the treatment of medically refractory tremor by discussing its history, defining the technique and its indications, evaluating its efficacy, and exploring its complications and shortcomings.

© 2018 S. Karger AG, Basel


References

  1. Brin MF, Koller W: Epidemiology and genetics of essential tremor. Mov Disord 1998;13(suppl 3):55-63.
  2. Bagepally BS, Bhatt MD, Chandran V, Saini J, Bharath RD, Vasudev MK, Prasad C, Yadav R, Pal PK: Decrease in cerebral and cerebellar gray matter in essential tremor: a voxel-based morphometric analysis under 3T MRI. J Neuroimaging 2012;22:275-278.
  3. Daniels C, Peller M, Wolff S, Alfke K, Witt K, Gaser C, Jansen O, Siebner HR, Deuschl G: Voxel-based morphometry shows no decreases in cerebellar gray matter volume in essential tremor. Neurology 2006;67:1452-1456.
  4. Deuschl G, Elble RJ: The pathophysiology of essential tremor. Neurology 2000;54:S14-S20.
  5. Elble RJ: Central mechanisms of tremor. J Clin Neurophysiol 1996;13:133-144.
  6. Louis ED: Essential tremor: from bedside to bench and back to bedside. Curr Opin Neurol 2014;27:461-467.
  7. Mure H, Hirano S, Tang CC, Isaias IU, Antonini A, Ma Y, Dhawan V, Eidelberg D: Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects. Neuroimage 2011;54:1244-1253.
  8. Helmich RC, Janssen MJ, Oyen WJ, Bloem BR, Toni I: Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor. Ann Neurol 2011;69:269-281.
  9. Leigh PN, Jefferson D, Twomey A, Marsden CD: Beta-adrenoreceptor mechanisms in essential tremor; a double-blind placebo controlled trial of metoprolol, sotalol and atenolol. J Neurol Neurosurg Psychiatry 1983;46:710-715.
  10. Baker MR, Baker SN: Beta-adrenergic modulation of tremor and corticomuscular coherence in humans. PLoS One 2012;7:e49088.
  11. Goetz CG, Pal G: Initial management of Parkinson's disease. BMJ 2014;349:g6258.
  12. Jeanmonod D, Werner B, Morel A, Michels L, Zadicario E, Schiff G, Martin E: Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain. Neurosurg Focus 2012;32:E1.
  13. Martin E, Jeanmonod D, Morel A, Zadicario E, Werner B: High-intensity focused ultrasound for noninvasive functional neurosurgery. Ann Neurol 2009;66:858-861.
  14. Goldman MS, Ahlskog JE, Kelly PJ: The symptomatic and functional outcome of stereotactic thalamotomy for medically intractable essential tremor. J Neurosurg 1992;76:924-928.
  15. Goldman MS, Kelly PJ: Symptomatic and functional outcome of stereotactic ventralis lateralis thalamotomy for intention tremor. J Neurosurg 1992;77:223-229.
  16. Kondziolka D, Ong JG, Lee JY, Moore RY, Flickinger JC, Lunsford LD: Gamma Knife thalamotomy for essential tremor. J Neurosurg 2008;108:111-117.
  17. Lyons KE, Pahwa R: Deep brain stimulation and essential tremor. J Clin Neurophysiol 2004;21:2-5.
  18. Bar-Gad I, Elias S, Vaadia E, Bergman H: Complex locking rather than complete cessation of neuronal activity in the globus pallidus of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primate in response to pallidal microstimulation. J Neurosci 2004;24:7410-7419.
  19. Meissner W, Leblois A, Hansel D, Bioulac B, Gross CE, Benazzouz A, Boraud T: Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain 2005;128:2372-2382.
  20. Tai CH, Boraud T, Bezard E, Bioulac B, Gross C, Benazzouz A: Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata. FASEB J 2003;17:1820-1830.
  21. Spiegel EA, Wycis HT: Effect of thalamic and pallidal lesions upon involuntary movements in choreoathetosis. Trans Am Neurol Assoc 1950;51:234-237.
  22. Spiegel EA, Wycis HT: Thalamotomy and pallidotomy for treatment of choreic movements. Acta Neurochir (Wien) 1952;2:417-422.
  23. Spiegel EA, Wycis HT, Baird HW 3rd: Long-range effects of electropallidoansotomy in extrapyramidal and convulsive disorders. Neurology 1958;8:734-740.
  24. Cooper IS: Intracerebral injection of procaine into the globus pallidus in hyperkinetic disorders. Science 1954;119:417-418.
  25. Narabayashi H, Okuma T, Shikiba S: Procaine oil blocking of the globus pallidus. AMA Arch Neurol Psychiatry 1956;75:36-48.
  26. Bravo GJ, Cooper IS: A clinical and radiological correlation of the lesions produced by chemopallidectomy and thalamectomy. J Neurol Neurosurg Psychiatry 1959;22:1-10.
  27. Alberts WW, Feinstein B, Levin G, Wright EW Jr, Darland MG, Scott EL: Stereotaxic surgery for parkinsonism. Clinical results and stimulation thresholds. J Neurosurg 1965;23:174-183.
  28. Redfern RM: History of stereotactic surgery for Parkinson's disease. Br J Neurosurg 1989;3:271-304.
  29. Larsson B, Lidén K, Sarby B: Irradiation of small structures through the intact skull. Acta Radiol Ther Phys Biol 1974;13:512-534.
  30. Leksell L, Lindquist C, Adler JR, Leksell D, Jernberg B, Steiner L: A new fixation device for the Leksell stereotaxic system. Technical note. J Neurosurg 1987;66:626-629.
  31. Leksell L: Cerebral radiosurgery. I. Gammathalanotomy in two cases of intractable pain. Acta Chir Scand 1968;134:585-595.
  32. Steiner L, Forster D, Leksell L, Meyerson BA, Boëthius J: Gammathalamotomy in intractable pain. Acta Neurochir (Wien) 1980;52:173-184.
  33. Leksell L: The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951;102:316-319.
  34. Lindquist C, Kihlström L, Hellstrand E: Functional neurosurgery-a future for the gamma knife? Stereotact Funct Neurosurg 1991;57:72-81.
  35. Ohye C, Shibazaki T, Hirato M, Inoue H, Andou Y: Gamma thalamotomy for parkinsonian and other kinds of tremor. Stereotact Funct Neurosurg 1996;66(suppl 1):333-342.
  36. Ohye C, Shibazaki T, Zhang J, Andou Y: Thalamic lesions produced by gamma thalamotomy for movement disorders. J Neurosurg 2002;97:600-606.
  37. Young RF, Li F, Vermeulen S, Meier R: Gamma Knife thalamotomy for treatment of essential tremor: long-term results. J Neurosurg 2010;112:1311-1317.
  38. Elaimy AL, Demakas JJ, Arthurs BJ, Cooke BS, Fairbanks RK, Lamoreaux WT, Mackay AR, Greeley DR, Lee CM: Gamma knife radiosurgery for essential tremor: a case report and review of the literature. World J Surg Oncol 2010;8:20.
  39. Ohye C, Higuchi Y, Shibazaki T, Hashimoto T, Koyama T, Hirai T, Matsuda S, Serizawa T, Hori T, Hayashi M, Ochiai T, Samura H, Yamashiro K: Gamma knife thalamotomy for Parkinson disease and essential tremor: a prospective multicenter study. Neurosurgery 2012;70:526-535; discussion 535-526.
  40. Kooshkabadi A, Lunsford LD, Tonetti D, Flickinger JC, Kondziolka D: Gamma Knife thalamotomy for tremor in the magnetic resonance imaging era. J Neurosurg 2013;118:713-718.
  41. Kondziolka D: Gamma knife thalamotomy for disabling tremor. Arch Neurol 2002;59:1660; author reply 1662-1664.
  42. Fahn S, Tolosa E: Clinical rating scale for tremor; in Jankovic J, (eds): Parkinson's Disease and Movement Disorders. edition 2, Baltimore, Williams and Wilkins, 1993, pp 271-280.
  43. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N; Movement Disorder Society UPDRS Revision Task Force: Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23:2129-2170.
  44. Jankovic J, Schwartz K, Clemence W, Aswad A, Mordaunt J: A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord 1996;11:250-256.
  45. Young RF, Jacques S, Mark R, Kopyov O, Copcutt B, Posewitz A, Li F: Gamma knife thalamotomy for treatment of tremor: long-term results. J Neurosurg 2000;93(suppl 3):128-135.
  46. Bahgat D, Magill ST, Berk C, McCartney S, Burchiel KJ: Thalamotomy as a treatment option for tremor after ineffective deep brain stimulation. Stereotact Funct Neurosurg 2013;91:18-23.
  47. Niranjan A, Jawahar A, Kondziolka D, Lunsford LD: A comparison of surgical approaches for the management of tremor: radiofrequency thalamotomy, gamma knife thalamotomy and thalamic stimulation. Stereotact Funct Neurosurg 1999;72:178-184.
  48. Campbell AM, Glover J, Chiang VL, Gerrard J, Yu JB: Gamma knife stereotactic radiosurgical thalamotomy for intractable tremor: a systematic review of the literature. Radiother Oncol 2015;114:296-301.
  49. Lim SY, Hodaie M, Fallis M, Poon YY, Mazzella F, Moro E: Gamma knife thalamotomy for disabling tremor: a blinded evaluation. Arch Neurol 2010;67:584-588.
  50. Witjas T, Carron R, Krack P, Eusebio A, Vaugoyeau M, Hariz M, Azulay JP, Regis J: A prospective single-blind study of Gamma Knife thalamotomy for tremor. Neurology 2015;85:1562-1568.
  51. Okun MS, Stover NP, Subramanian T, Gearing M, Wainer BH, Holder CA, Watts RL, Juncos JL, Freeman A, Evatt ML, Schuele SU, Vitek JL, DeLong MR: Complications of gamma knife surgery for Parkinson disease. Arch Neurol 2001;58:1995-2002.
  52. Pan L, Dai JZ, Wang BJ, Xu WM, Zhou LF, Chen XR: Stereotactic Gamma thalamotomy for the treatment of parkinsonism. Stereotact Funct Neurosurg 1996;66(suppl 1):329-332.
  53. Ohye C, Shibazaki T, Ishihara J, Zhang J: Evaluation of gamma thalamotomy for parkinsonian and other tremors: survival of neurons adjacent to the thalamic lesion after gamma thalamotomy. J Neurosurg 2000;93(suppl 3):120-127.
  54. Siderowf A, Gollump SM, Stern MB, Baltuch GH, Riina HA: Emergence of complex, involuntary movements after gamma knife radiosurgery for essential tremor. Mov Disord 2001;16:965-967.
  55. Duma CM, Jacques DB, Kopyov OV, Mark RJ, Copcutt B, Farokhi HK: Gamma knife radiosurgery for thalamotomy in parkinsonian tremor: a five-year experience. J Neurosurg 1998;88:1044-1049.
  56. Friedman DP, Goldman HW, Flanders AE, Gollomp SM, Curran WJ Jr: Stereotactic radiosurgical pallidotomy and thalamotomy with the gamma knife: MR imaging findings with clinical correlation-preliminary experience. Radiology 1999;212:143-150.

Article / Publication Details

First-Page Preview
Abstract of  

Published online: January 12, 2018
Cover Date: 2018

Number of Print Pages: 14
Number of Figures: 3
Number of Tables: 2

ISBN: 978-3-318-06201-4 (Print)
eISBN: 978-3-318-06202-1 (Online)


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.